• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于壳聚糖的纳米递送系统的合成与表征,以增强索拉非尼药物对肝癌和大肠腺癌细胞的抗癌作用。

Synthesis and Characterization of Chitosan-Based Nanodelivery Systems to Enhance the Anticancer Effect of Sorafenib Drug in Hepatocellular Carcinoma and Colorectal Adenocarcinoma Cells.

作者信息

Ruman Umme, Buskaran Kalaivani, Pastorin Giorgia, Masarudin Mas Jaffri, Fakurazi Sharida, Hussein Mohd Zobir

机构信息

Materials Synthesis and Characterization Laboratory, Institute of Advanced Technology (ITMA), Universiti Putra Malaysia, UPM Serdang 43400, Selangor, Malaysia.

Laboratory of Vaccine and Immunotherapeutic, Institute of Bioscience Universiti Putra Malaysia, UPM Serdang 43400, Selangor, Malaysia.

出版信息

Nanomaterials (Basel). 2021 Feb 16;11(2):497. doi: 10.3390/nano11020497.

DOI:10.3390/nano11020497
PMID:33669332
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7920308/
Abstract

The formation of two nanodelivery systems, Sorafenib (SF)-loaded chitosan (SF-CS) and their folate-coated (SF-CS-FA) nanoparticles (NPs), were developed to enhance SF drug delivery on human Hepatocellular Carcinoma (HepG2) and Colorectal Adenocarcinoma (HT29) cell lines. The ionic gelation method was adopted to synthesize the NPs. The characterizations were performed by DLS, FESEM, TEM, XRD, TGA, FTIR, and UV-visible spectroscopy. It was found that 83.7 ± 2.4% and 87.9 ± 1.1% of encapsulation efficiency; 18.2 ± 1.3% and 19.9 ± 1.4% of loading content; 76.3 ± 13.7 nm and 81.6 ± 12.9 nm of hydrodynamic size; 60-80 nm and 70-100 nm of TEM; and FESEM sizes of near-spherical shape were observed, respectively, for SF-CS and SF-CS-FA nanoparticles. The SF showed excellent release from the nanoparticles under pH 4.8 PBS solution, indicating a good delivery system for tumor cells. The cytotoxicity study revealed their better anticancer action towards HepG2 and HT29 cell lines compared to the free sorafenib. Moreover, both NPs systems showed negligible toxicity to normal Human Dermal Fibroblast adult cells (HDFa). This is towards an enhanced anticancer drug delivery system with sustained-release properties for better cancer management.

摘要

开发了两种纳米递送系统,即载有索拉非尼(SF)的壳聚糖(SF-CS)及其叶酸包被(SF-CS-FA)纳米颗粒(NPs),以增强SF对人肝癌(HepG2)和结肠腺癌(HT29)细胞系的药物递送。采用离子凝胶法合成纳米颗粒。通过动态光散射(DLS)、场发射扫描电子显微镜(FESEM)、透射电子显微镜(TEM)、X射线衍射(XRD)、热重分析(TGA)、傅里叶变换红外光谱(FTIR)和紫外可见光谱进行表征。结果发现,SF-CS和SF-CS-FA纳米颗粒的包封率分别为83.7±2.4%和87.9±1.1%;载药量分别为18.2±1.3%和19.9±1.4%;流体动力学尺寸分别为76.3±13.7nm和81.6±12.9nm;TEM尺寸分别为60-80nm和70-100nm;FESEM尺寸均为近球形。SF在pH 4.8的磷酸盐缓冲盐水(PBS)溶液中从纳米颗粒中显示出优异的释放性能,表明其是一种良好的肿瘤细胞递送系统。细胞毒性研究表明,与游离索拉非尼相比,它们对HepG2和HT29细胞系具有更好的抗癌作用。此外,两种纳米颗粒系统对正常人皮肤成纤维细胞(HDFa)的毒性均可忽略不计。这是朝着具有缓释特性的增强抗癌药物递送系统发展,以更好地管理癌症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc83/7920308/287e623dc0cc/nanomaterials-11-00497-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc83/7920308/f304761991b8/nanomaterials-11-00497-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc83/7920308/6f471f6fb2e4/nanomaterials-11-00497-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc83/7920308/e81a80dfdda2/nanomaterials-11-00497-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc83/7920308/e2b4fccb974f/nanomaterials-11-00497-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc83/7920308/92fdeeafd693/nanomaterials-11-00497-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc83/7920308/40ddae12283c/nanomaterials-11-00497-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc83/7920308/e15d7e70dee1/nanomaterials-11-00497-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc83/7920308/103c77d104ad/nanomaterials-11-00497-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc83/7920308/03e2317bd46b/nanomaterials-11-00497-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc83/7920308/81565f0fcd8a/nanomaterials-11-00497-g010a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc83/7920308/90e19c10ed98/nanomaterials-11-00497-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc83/7920308/6fc8cd1c01ab/nanomaterials-11-00497-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc83/7920308/fdf049ccf101/nanomaterials-11-00497-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc83/7920308/fe3528d511da/nanomaterials-11-00497-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc83/7920308/287e623dc0cc/nanomaterials-11-00497-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc83/7920308/f304761991b8/nanomaterials-11-00497-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc83/7920308/6f471f6fb2e4/nanomaterials-11-00497-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc83/7920308/e81a80dfdda2/nanomaterials-11-00497-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc83/7920308/e2b4fccb974f/nanomaterials-11-00497-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc83/7920308/92fdeeafd693/nanomaterials-11-00497-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc83/7920308/40ddae12283c/nanomaterials-11-00497-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc83/7920308/e15d7e70dee1/nanomaterials-11-00497-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc83/7920308/103c77d104ad/nanomaterials-11-00497-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc83/7920308/03e2317bd46b/nanomaterials-11-00497-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc83/7920308/81565f0fcd8a/nanomaterials-11-00497-g010a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc83/7920308/90e19c10ed98/nanomaterials-11-00497-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc83/7920308/6fc8cd1c01ab/nanomaterials-11-00497-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc83/7920308/fdf049ccf101/nanomaterials-11-00497-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc83/7920308/fe3528d511da/nanomaterials-11-00497-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc83/7920308/287e623dc0cc/nanomaterials-11-00497-g015.jpg

相似文献

1
Synthesis and Characterization of Chitosan-Based Nanodelivery Systems to Enhance the Anticancer Effect of Sorafenib Drug in Hepatocellular Carcinoma and Colorectal Adenocarcinoma Cells.基于壳聚糖的纳米递送系统的合成与表征,以增强索拉非尼药物对肝癌和大肠腺癌细胞的抗癌作用。
Nanomaterials (Basel). 2021 Feb 16;11(2):497. doi: 10.3390/nano11020497.
2
Fabrication and characterization of nanodelivery platform based on chitosan to improve the anticancer outcome of sorafenib in hepatocellular carcinoma.基于壳聚糖的纳米递药平台的构建及表征,以提高索拉非尼在肝癌中的抗癌效果。
Sci Rep. 2023 Jul 27;13(1):12180. doi: 10.1038/s41598-023-38054-4.
3
The enzyme-sensitive release of prodigiosin grafted β-cyclodextrin and chitosan magnetic nanoparticles as an anticancer drug delivery system: Synthesis, characterization and cytotoxicity studies.载姜黄素的β-环糊精和壳聚糖磁性纳米粒子作为一种抗癌药物输送系统的酶敏感释放:合成、表征和细胞毒性研究。
Colloids Surf B Biointerfaces. 2017 Oct 1;158:589-601. doi: 10.1016/j.colsurfb.2017.07.044. Epub 2017 Jul 18.
4
5-Fluorouracil-Loaded Folic-Acid-Fabricated Chitosan Nanoparticles for Site-Targeted Drug Delivery Cargo.用于靶向给药的负载5-氟尿嘧啶的叶酸修饰壳聚糖纳米粒
Polymers (Basel). 2022 May 13;14(10):2010. doi: 10.3390/polym14102010.
5
In Silico design of AVP (4-5) peptide and synthesis, characterization and in vitro activity of chitosan nanoparticles.AVP(4-5)肽的计算机设计、壳聚糖纳米粒子的合成、表征和体外活性
Daru. 2020 Jun;28(1):139-157. doi: 10.1007/s40199-019-00325-9. Epub 2020 Jan 16.
6
Enhancing anti-tumor efficiency in hepatocellular carcinoma through the autophagy inhibition by miR-375/sorafenib in lipid-coated calcium carbonate nanoparticles.通过脂质包覆碳酸钙纳米粒子中的 miR-375/索拉非尼抑制自噬来增强肝癌的抗肿瘤效率。
Acta Biomater. 2018 May;72:248-255. doi: 10.1016/j.actbio.2018.03.022. Epub 2018 Mar 17.
7
Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability.新型多西紫杉醇壳聚糖包覆的 PLGA/PCL 纳米粒,具有增强的细胞毒性和生物利用度。
Biomed Pharmacother. 2018 Oct;106:1461-1468. doi: 10.1016/j.biopha.2018.07.102. Epub 2018 Jul 24.
8
Synthesis, characterization and cytotoxicity studies of chitosan-coated tea polyphenols nanoparticles.壳聚糖包覆茶多酚纳米粒的合成、表征及细胞毒性研究。
Colloids Surf B Biointerfaces. 2011 Feb 1;82(2):297-301. doi: 10.1016/j.colsurfb.2010.08.045. Epub 2010 Sep 9.
9
Synthesis and characterization of folate conjugated chitosan and cellular uptake of its nanoparticles in HT-29 cells.叶酸偶联壳聚糖的合成与表征及其纳米粒在 HT-29 细胞中的摄取。
Carbohydr Res. 2011 May 1;346(6):801-6. doi: 10.1016/j.carres.2011.01.027.
10
Chitosan based sorafenib tosylate loaded magnetic nanoparticles: Formulation and in-vitro characterization.壳聚糖载索拉非尼甲苯磺酸盐磁性纳米粒子的制备及体外评价。
Int J Biol Macromol. 2023 Jul 1;242(Pt 2):124919. doi: 10.1016/j.ijbiomac.2023.124919. Epub 2023 May 15.

引用本文的文献

1
Anti-cancer properties of chitosan /Lactobacillus acidophilus secretome nanoparticle on signaling pathways of colorectal cancer in colon adenocarcinoma (Caco-2) cell line.壳聚糖/嗜酸乳杆菌分泌组纳米颗粒对结肠腺癌(Caco-2)细胞系中结直肠癌信号通路的抗癌特性
BMC Cancer. 2025 Jun 2;25(1):983. doi: 10.1186/s12885-025-14315-5.
2
Effect of chitosan nanoparticles conjugated with the cell free supernatant of Bifidobacterium bifidum on the expression of genes related to colorectal cancer in colon adenocarcinoma (Caco-2) cell line.与两歧双歧杆菌无细胞上清液结合的壳聚糖纳米颗粒对结肠腺癌(Caco-2)细胞系中与结直肠癌相关基因表达的影响。
BMC Gastroenterol. 2025 May 21;25(1):394. doi: 10.1186/s12876-025-03923-x.
3

本文引用的文献

1
Decreasing acute toxicity and suppressing colorectal carcinoma using Sorafenib-loaded nanoparticles.载索拉非尼纳米粒降低急性毒性和抑制结直肠癌。
Pharm Dev Technol. 2020 Jun;25(5):556-565. doi: 10.1080/10837450.2020.1718704. Epub 2020 Feb 2.
2
Design And Characterisation Of Novel Sorafenib-Loaded Carbon Nanotubes With Distinct Tumour-Suppressive Activity In Hepatocellular Carcinoma.新型索拉非尼负载碳纳米管的设计与表征及其在肝癌中的抑瘤活性。
Int J Nanomedicine. 2019 Oct 29;14:8445-8467. doi: 10.2147/IJN.S223920. eCollection 2019.
3
Evaluation of the Release Kinetics of a Pharmacologically Active Substance from Model Intra-Articular Implants Replacing the Cruciate Ligaments of the Knee.
Niosome as a Drug Delivery Carrier for Sorafenib: Preparation, Investigation of Physicochemical Properties, and Effects on HepG2 Cell Line.
纳米囊泡作为索拉非尼的药物递送载体:制备、理化性质研究及其对肝癌细胞系HepG2的影响
Adv Pharm Bull. 2024 Dec 30;14(4):836-845. doi: 10.34172/apb.43228. Epub 2024 Oct 2.
4
Application of pumpkin-leaf protein concentrate as a matrix component for the encapsulation of folic acid.南瓜叶浓缩蛋白作为叶酸包封基质成分的应用。
Food Chem X. 2025 Feb 24;26:102310. doi: 10.1016/j.fochx.2025.102310. eCollection 2025 Feb.
5
Almond Hull Extract Valorization: From Waste to Food Recovery to Counteract and in Formation and Mature Biofilm.杏仁壳提取物的价值提升:从废物到食物回收以对抗生物膜的形成和成熟生物膜。
Foods. 2024 Nov 28;13(23):3834. doi: 10.3390/foods13233834.
6
Formulation development, characterization, and evaluation of sorafenib-loaded PLGA-chitosan nanoparticles.载索拉非尼的聚乳酸-羟基乙酸共聚物-壳聚糖纳米粒的处方开发、表征及评价
Front Pharmacol. 2024 Oct 9;15:1465363. doi: 10.3389/fphar.2024.1465363. eCollection 2024.
7
Biomaterial-Based Responsive Nanomedicines for Targeting Solid Tumor Microenvironments.用于靶向实体瘤微环境的基于生物材料的响应性纳米药物。
Pharmaceutics. 2024 Jan 26;16(2):179. doi: 10.3390/pharmaceutics16020179.
8
Cytotoxicity Enhancement of α-Mangostin with Folate-Conjugated Chitosan Nanoparticles in MCF-7 Breast Cancer Cells.α-倒捻子素与叶酸修饰壳聚糖纳米粒联合对 MCF-7 乳腺癌细胞的细胞毒性增强作用。
Molecules. 2023 Nov 14;28(22):7585. doi: 10.3390/molecules28227585.
9
Carbon Nanomaterials (CNMs) in Cancer Therapy: A Database of CNM-Based Nanocarrier Systems.癌症治疗中的碳纳米材料(CNMs):基于CNM的纳米载体系统数据库
Pharmaceutics. 2023 May 19;15(5):1545. doi: 10.3390/pharmaceutics15051545.
10
Amygdalin-folic acid-nanoparticles inhibit the proliferation of breast cancer and enhance the effect of radiotherapy through the modulation of tumor-promoting factors/ immunosuppressive modulators in vitro.杏仁酸-叶酸-纳米粒子通过调节肿瘤促进因子/免疫抑制调节剂在体外抑制乳腺癌的增殖,并增强放射治疗的效果。
BMC Complement Med Ther. 2023 May 20;23(1):162. doi: 10.1186/s12906-023-03986-x.
评估替代膝关节交叉韧带的模型关节内植入物中药理活性物质的释放动力学。
Materials (Basel). 2019 Apr 12;12(8):1202. doi: 10.3390/ma12081202.
4
Employment of enhanced permeability and retention effect (EPR): Nanoparticle-based precision tools for targeting of therapeutic and diagnostic agent in cancer.增强型渗透和保留效应(EPR)的应用:基于纳米颗粒的精准工具,用于靶向治疗和诊断剂在癌症中的应用。
Mater Sci Eng C Mater Biol Appl. 2019 May;98:1252-1276. doi: 10.1016/j.msec.2019.01.066. Epub 2019 Jan 18.
5
Exploring the efficacy and cellular uptake of sorafenib in colon cancer cells by Raman micro-spectroscopy.应用拉曼微光谱技术探索索拉非尼对结肠癌细胞的疗效和细胞摄取。
Analyst. 2018 Dec 3;143(24):6069-6078. doi: 10.1039/c8an02029a.
6
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
7
Controlled drug delivery vehicles for cancer treatment and their performance.用于癌症治疗的控释药物输送载体及其性能。
Signal Transduct Target Ther. 2018 Mar 16;3:7. doi: 10.1038/s41392-017-0004-3. eCollection 2018.
8
Update on Nanotechnology-based Drug Delivery Systems in Cancer Treatment.癌症治疗中基于纳米技术的药物递送系统的最新进展
Anticancer Res. 2017 Nov;37(11):5975-5981. doi: 10.21873/anticanres.12044.
9
Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis.肝癌细胞起源、分子亚型及其对患者预后的影响。
Gastroenterology. 2017 Mar;152(4):745-761. doi: 10.1053/j.gastro.2016.11.048. Epub 2016 Dec 30.
10
Hepatocellular Carcinoma: Therapeutic Guidelines and Medical Treatment.肝细胞癌:治疗指南与医学治疗
Liver Cancer. 2016 Nov;6(1):16-26. doi: 10.1159/000449343. Epub 2016 Nov 29.